期刊文献+

rCBV在T2^*-PWI鉴别脑胶质瘤复发与放射性坏死中的价值 被引量:1

下载PDF
导出
摘要 目的:探讨rCBV在T2^*-PWI脑胶质瘤复发与放射性坏死鉴别诊断中的应用价值。方法15例放射性坏死、9例脑胶质瘤复发患者在3.0T磁共振仪作传统平扫及增强的基础上行T2^*-PWI,后处理在Philips EWS工作站完成。分别以病灶强化区、水肿区及正常对照区为感兴趣区,得到nrCBV值,以独立样本t检验比较脑胶质瘤复发及放射性坏死病灶的强化区、水肿区nrCBV值的差异。结果脑胶质瘤复发病灶的强化区与水肿区nrCBV值均高于放射性坏死区。脑胶质瘤复发病灶的强化区与水肿区nrCBV值分别为(3.27±2.32)和(1.17±0.56),放射性坏死病灶的强化区与水肿区nrCBV值分别为(0.97±0.57)和(0.58±0.22),强化区nrCBV值的诊断敏感性及特异性分别为88.2%和97.4%,而水肿区为92.3%和100%。结论脑胶质瘤复发病灶的强化区与水肿区nrCBV值均高于放射性坏死,利用T2^*-灌注加权成像可以提高脑胶质瘤复发与放射性坏死的鉴别诊断正确率。 Objective To investigates the T2^*-perfusion-weighted imaging to improve the differential diagnosis between the glioma recurrence and radiation necrosis. Materials and Methods Fifteen cases of radiation injury and 9 cases of glioma recurrence were retrospectively studied. The nrCBV values in the enhancing part,peri-local edema,and contralateral normal white matter were measured using a commercially available post-processing workstation. Results The nrCBV values in the enhancing part and peri-local edema of glioma recurrence were higher than those of radiation injury. The nrCBV values in the enhancing part of glioma recurrence and radiation injury were 3.27±2.32 and 1.17±0.56,and in the peri-local edema,they were 0.97±0.57 and 0.58±0.22,respectively. The sensitivity and specificity of nrCBV values in the enhancing part were 88.2%and 97.4%,and in the peri-local edem were 92.3%and 100%,respectively. Conclusion The nrCBV value of Glioma recurrence was higher than the radiation necrosis.The T2^*-perfusion-weighted imaging can significantly improve the differential diagnosis between glioma recurrence and radiation necrosis.
出处 《浙江临床医学》 2014年第10期1534-1536,共3页 Zhejiang Clinical Medical Journal
关键词 胶质瘤 放射性坏死 肿瘤复发 T2^*-PWI Glioma Radiation necrosis Tumor recurrence Perfusion-weighted imaging
  • 相关文献

参考文献11

  • 1Chen F, Zhang X, Li M, et al. Axial diffusivity and tenor shape as early markers to assess cerebral white matter damage caused by brain tumors through the use of quantitative diffusion tensor tractography. CNS Neurosci Ther, 2012, 18(8):667-673.
  • 2张冰,朱斌.DWI在胶质瘤与单发转移瘤及其瘤周水肿中的诊断价值[J].中国医学计算机成像杂志,2006,12(2):80-83. 被引量:22
  • 3Fatterpekar GM, Galheigo D, Narayana A, et al. Treatment-related change versus tumor recurrence in high-Grade gliomas: a diagnostic conundrum-Use of dynamic susceptibility contrast-enhance(DSC) perfusion MRI. AJR, 2012, 198(1):19-26.
  • 4Tan H, Chen L, Guan Y, et al. Comparison ofMRI, F-18FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin Nucl Med, 2011, 36(11):978-981.
  • 5刘家斌,李广生.放射性脑损伤机制及放射保护研究进展[J].赣南医学院学报,2010,30(1):161-162. 被引量:13
  • 6Johannesen TB, Lien HH, Hole KH, et al. Radiological and Chnical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol, 2003, 69(2):169-176.
  • 7Barajas RF Jr, Chang JS, Segal M, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibiliy-weighted contrast- enhanced perfusion MR imaging. Radiology, 2009, 253(2):486-496.
  • 8Kumar AJ, Leeds NE, Fuller GN, et al.Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment. Radiology, 2000, 217(2):377-384.
  • 9Welzel T, Niethammer A, Mende U, et al. Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell Lung cancer: first results of a prospective study. AJNR, 2008, 29(2):379-3831.
  • 10Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood Volume values to differentiate high-grade glioma recurrence from post- treatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility weighted contrast- enhanced perfusion MR imaging measurements. AJNR, 2009, 30(3): 552-558.

二级参考文献10

共引文献30

同被引文献19

  • 1Barajas RF Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. Radiology, 2009, 253(2): 486-496.
  • 2Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, et al Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol, 2010, 48(2): 81-92.
  • 3Cha J, Kim ST, Kim HJ, et al. Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis. AJNR Am J Neuroradiol, 2014, 35(7): 1309-1317.
  • 4Di Costanzo A, Scarabino T, Trojsi F, et al. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. Radiol Med, 2014, 119(8): 616-624.
  • 5Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol, 2009, 30(3): 552-558.
  • 6Hu X, Wong KK, Young GS, et al. Support vector machine multiparametric MR/identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging, 2011, 33(2): 296-305.
  • 7Kim YH, Oh SW, Lim YJ, et al. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MR/. Clin Neurol Neurosurg, 2010, 112(9): 758-765.
  • 8Martinez-Martinez A, Martinez-Bosch J. Perfusion magnetic resonance imaging for high grade astrocytomas: can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression? Radiologia, 2014, 56(1): 35-43.
  • 9Ozsunar Y, Mullins ME, Kwong K, et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin- labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol, 2010, 17(3): 282-290.
  • 10Prat R, Galeano I, Lucas A, et al. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2- (18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas. J Clin Neurosci, 2010, 17(1): 50-53.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部